Accelerating the Development of Genomic Vaccines – Insights into Lipid Nanoparticle Design and Scalable Microfluidic Manufacturing
Time: 10:50 am
day: Day One
- Acknowledging the complexities and challenges for developing genomic cancer vaccines and how it is critical to have a scalable and robust manufacturing platform for the development of non-viral delivery methods.
- Sharing insights into a scalable manufacturing platform for RNA-LNPs and the use of this technology for the development of a high-potency self-amplifying (saRNA) LNP vaccine.
- Highlighting some of the key considerations for the development of a LNP vaccine drug product.